FUSEN PHARM (01652) Appoints Zhongzheng Tianheng as New Auditor

Stock News
Dec 24

FUSEN PHARM (01652) announced that KPMG has resigned as the company's auditor effective December 24, 2025, due to the board's failure to reach an agreement on proposed audit fees for the group's consolidated financial statements for the fiscal year ending December 31, 2025. Upon the recommendation of the audit committee, Zhongzheng Tianheng Certified Public Accountants Co., Ltd. has been appointed as the new auditor to fill the vacancy left by KPMG. The appointment takes effect from December 24, 2025, and will remain valid until the conclusion of the company's next annual general meeting.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10